| |
| |
|
| Insider
Information: |
Parker Albert P |
| Relationship: |
|
| City: |
Alameda |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
10,586 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,090 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
10,586 |
|
|
| Total
Value |
$2,090 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Oncocyte Corp |
OCX |
COO |
2020-12-11 |
10,586 |
|
0 |
Premium* |
|
|
Zynerba Pharmaceuticals, Inc. |
ZYNE |
|
2023-10-10 |
0 |
2022-02-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ZYNE |
Zynerba Pharmaceuticals, ... |
Chief Legal Officer |
• • – |
2023-10-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(312,018) |
0 |
0 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
Chief Legal Officer |
• • – |
2023-10-10 |
4 |
A |
$0.00 |
$0 |
D/D |
85,000 |
278,333 |
0 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
Chief Legal Officer |
• – – |
2023-02-15 |
4 |
S |
$0.54 |
$1,719 |
D/D |
(3,173) |
227,018 |
0 |
% |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
Chief Legal Officer |
• – – |
2023-02-08 |
4 |
D |
$0.60 |
$3,259 |
D/D |
(5,463) |
230,191 |
0 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
Chief Legal Officer |
• – – |
2023-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
18,864 |
235,654 |
0 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
Chief Legal Officer |
• – – |
2023-02-01 |
4 |
D |
$0.60 |
$3,477 |
D/D |
(5,841) |
216,790 |
0 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
Chief Legal Officer |
• – – |
2023-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
17,631 |
222,631 |
0 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
Chief Legal Officer |
• – – |
2023-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
170,000 |
205,000 |
0 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
Chief Legal Officer |
• – – |
2022-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
35,000 |
0 |
- |
|
| OCX |
Oncocyte Corp |
COO |
• – – |
2020-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
5,586 |
10,586 |
0 |
- |
|
| OCX |
Oncocyte Corp |
Chief Operating Officer |
• – – |
2020-08-03 |
4 |
B |
$1.33 |
$6,648 |
D/D |
5,000 |
5,000 |
2.74 |
% |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
